Tags : Post-AFib Ablation

Boston Scientific Initiates OPTION Study of Watchman FLX Device for

Shots: The OPTION study involves assessing of Watchman FLX left atrial appendage closure vs oral anticoagulants (OAC) including direct oral anticoagulants (DOAC) & warfarin in 1,600 patients with non-valvular AF who undergo a cardiac ablation across 130 sites globally The OPTION study will have its 1EPs as all cause death, stroke and systemic embolism with […]Read More